Why Boston Scientific (BSX) shares are plunging today
What happened? Shares of medical device company Boston Scientific (NYSE:BSX) fell 8% in the morning session after the company reported third-quarter 2026 fin... Shares of Boston Scientific (BSX) fell 8% after the company reported its third-quarter 2026 financial results, showing a 1.5% growth in net sales and highlighting efforts to restore operations following a cybersecurity incident. The company posted GAAP net income attributable to common stockholders of $582 million or $0.40 per share, with adjusted earnings per share reaching $073 vs S&P analysts’ estimates of $00.72. Despite the strong results, investor attention shifted to the company's outlook, which was overshadowed by the strong quarterly results. The shares have fallen 55.7% since the beginning of the year and are now trading 60.1% below their 52-week high of $104.98 from November 2025.
Publié : il y a 5 heures par Radek Strnad dans Business Health Finance
Shares of medical device company Boston Scientific (NYSE:BSX) fell 8% in the morning session after the company reported third-quarter 2026 financial results showing net sales growth of 1.5 percent and... [3058 symbols]
